TOPICAL FORMULATION CONTAINING ALCLOMETASONE AND MUPIROCIN

摘要

The present invention discloses a novel pharmaceutical formulation comprising a combination of alclometasone and mupiriocin alongwith pharmaceutically acceptable excipients for treatment of infectious eczematoid dermatitis.